{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:26:35Z","timestamp":1788387995984,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Anti-NMDA receptor encephalitis (NMDAR-E) is an autoimmune encephalitis (AE) mainly affecting young females. It typically presents with isolated psychiatric symptoms\u00a0(e.g. depressed mood) at first and neurological abnormalities (e.g. seizures, movement disorders) only develop later. Thus, there is a high risk of overlooking NMDAR-E in patients with preexisting psychiatric illness due to symptom overlap in the prodromal period of the disease when treatment is most effective. Although rare, concomitant or sequential development of a demyelinating disorder is increasingly recognized as an associated disease entity (overlap syndrome), with immediate diagnostic and therapeutic implications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report a patient with a borderline personality disorder (BPD), which developed NMDAR-E and an overlapping demyelinating disorder with anti-Myelin oligodendrocyte glycoprotein (MOG) -IgG positivity. The initial clinical presentation with predominantly affective symptoms (e.g. mood lability, anxiety, depressed mood) lead us to suspect an exacerbation of the BPD at first. However, acute changes in premorbid behavior, newly developed psychotic symptoms and memory deficits lead us to the correct diagnosis of an AE, which was further complicated by the development of a demyelinating disorder. As a result of impaired illness awareness and psychosis, diagnostic and treatment was difficult to carry out. The symptoms completely remitted after treatment with methylprednisolone 1\u2009g daily for 5 days and 5 cycles of plasma exchange.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Continuous awareness for neuropsychiatric clinical warning signs in patients with a pre-diagnosed psychiatric disorder is important for a timely diagnosis. Therefore, we believe that the diagnostic and therapeutic algorithm provided here, for the first time specifically addressing patients with preexisting psychiatric illness and integrating overlap syndromes, can be a useful tool. Moreover, in order to timely perform diagnostics and treatment, judicial approval should be obtained rapidly.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-021-03269-0","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T09:03:48Z","timestamp":1626339828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Anti-NMDA receptor encephalitis and overlapping demyelinating disorder in a 20-year old female with borderline personality disorder: proposal of a diagnostic and therapeutic algorithm for autoimmune encephalitis in psychiatric patients \u201ccase report\u201d"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1333-6289","authenticated-orcid":false,"given":"David","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kertzscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Degering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"issue":"19","key":"3269_CR1","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1212\/WNL.0b013e3181fc2a06","volume":"75","author":"H Pr\u00fcss","year":"2010","unstructured":"Pr\u00fcss H, Dalmau J, Harms L, H\u00f6ltje M, Ahnert-Hilger G, Borowski K, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology. 2010;75(19):1735\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e3181fc2a06.","journal-title":"Neurology."},{"issue":"7","key":"3269_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00406-020-01113-2","volume":"270","author":"D Endres","year":"2020","unstructured":"Endres D, Leypoldt F, Bechter K, Hasan A, Steiner J, Domschke K, et al. Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations. Eur Arch Psychiatry Clin Neurosci. 2020;270(7):803\u201318. https:\/\/doi.org\/10.1007\/s00406-020-01113-2.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3269_CR3","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3389\/fneur.2019.01086","volume":"10","author":"D Endres","year":"2019","unstructured":"Endres D, Rauer S, Kern W, Venhoff N, Maier SJ, Runge K, et al. Psychiatric presentation of anti-NMDA receptor encephalitis. Front Neurol. 2019;10:1086. https:\/\/doi.org\/10.3389\/fneur.2019.01086.","journal-title":"Front Neurol"},{"issue":"3","key":"3269_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.24117","volume":"75","author":"MJ Titulaer","year":"2014","unstructured":"Titulaer MJ, H\u00f6ftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, et al. Overlapping demyelinating syndromes and anti\u2013N-methyl-D-aspartate receptor encephalitis. Ann Neurol. 2014;75(3):411\u201328. https:\/\/doi.org\/10.1002\/ana.24117.","journal-title":"Ann Neurol"},{"issue":"11","key":"3269_CR5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","volume":"18","author":"J Dalmau","year":"2019","unstructured":"Dalmau J, Armangu\u00e9 T, Planagum\u00e0 J, Radosevic M, Mannara F, Leypoldt F, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045\u201357. https:\/\/doi.org\/10.1016\/S1474-4422(19)30244-3.","journal-title":"Lancet Neurol"},{"issue":"4","key":"3269_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"3269_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","volume":"6","author":"A Al-Diwani","year":"2019","unstructured":"Al-Diwani A, Handel A, Townsend L, Pollak T, Leite MI, Harrison PJ, et al. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry. 2019;6(3):235\u201346. https:\/\/doi.org\/10.1016\/S2215-0366(19)30001-X.","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"3269_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","volume":"7","author":"TA Pollak","year":"2020","unstructured":"Pollak TA, Lennox BR, M\u00fcller S, Benros ME, Pr\u00fcss H, van Tebartz EL, et al. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry. 2020;7(1):93\u2013108. https:\/\/doi.org\/10.1016\/S2215-0366(19)30290-1.","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"3269_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177\u201389. https:\/\/doi.org\/10.1212\/WNL.0000000000001729.","journal-title":"Neurology."},{"issue":"0","key":"3269_CR10","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1111\/j.1468-1331.2007.02005.x","volume":"15","author":"H Kataoka","year":"2008","unstructured":"Kataoka H, Dalmau J, Ueno S. Paraneoplastic encephalitis associated with ovarian teratoma and N-methyl-D-aspartate receptor antibodies. Eur J Neurol. 2008;15(0):e5\u20136. https:\/\/doi.org\/10.1111\/j.1468-1331.2007.02005.x.","journal-title":"Eur J Neurol"},{"issue":"4","key":"3269_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391\u2013404. https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9.","journal-title":"Lancet Neurol"},{"key":"3269_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fpsyt.2017.00025","volume":"8","author":"J Herken","year":"2017","unstructured":"Herken J, Pr\u00fcss H. Red flags: clinical signs for identifying autoimmune encephalitis in psychiatric patients. Front Psychiatry. 2017;8:25. https:\/\/doi.org\/10.3389\/fpsyt.2017.00025.","journal-title":"Front Psychiatry"},{"issue":"5","key":"3269_CR13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00115-019-0700-z","volume":"90","author":"D Endres","year":"2019","unstructured":"Endres D, Bechter K, Pr\u00fcss H, Hasan A, Steiner J, Leypoldt F, et al. Autoantik\u00f6rper-assoziierte schizophreniforme Psychosen: klinische Symptomatik. Nervenarzt. 2019;90(5):547\u201363. https:\/\/doi.org\/10.1007\/s00115-019-0700-z.","journal-title":"Nervenarzt."},{"issue":"1","key":"3269_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12974-018-1067-y","volume":"15","author":"S Najjar","year":"2018","unstructured":"Najjar S, Steiner J, Najjar A, Bechter K. A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis. J Neuroinflammation. 2018;15(1):40. https:\/\/doi.org\/10.1186\/s12974-018-1067-y.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"3269_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00115-018-0499-z","volume":"89","author":"J Steiner","year":"2018","unstructured":"Steiner J, Pr\u00fc\u00df H, K\u00f6hler S, Hasan A, Falkai P. Autoimmunenzephalitis mit psychotischer Symptomatik : Diagnostik, Warnhinweise und praktisches Vorgehen. Nervenarzt. 2018;89(5):530\u20138. https:\/\/doi.org\/10.1007\/s00115-018-0499-z.","journal-title":"Nervenarzt."},{"issue":"7","key":"3269_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00115-019-0735-1","volume":"90","author":"EL van Tebartz","year":"2019","unstructured":"van Tebartz EL, Bechter K, Pr\u00fcss H, Hasan A, Steiner JH, Leypoldt F, et al. Autoantik\u00f6rper-assoziierte schizophreniforme Psychosen: Pathophysiologie. Diagn Ther Nerv. 2019;90(7):745\u201361. https:\/\/doi.org\/10.1007\/s00115-019-0735-1.","journal-title":"Diagn Ther Nerv"},{"key":"3269_CR17","doi-asserted-by":"publisher","first-page":"577124","DOI":"10.1016\/j.jneuroim.2019.577124","volume":"339","author":"CA P\u00e9rez","year":"2020","unstructured":"P\u00e9rez CA, Agyei P, Gogia B, Harrison R, Samudralwar R. Overlapping autoimmune syndrome: a case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease. J Neuroimmunol. 2020;339:577124. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577124.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"3269_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","volume":"15","author":"S Jarius","year":"2018","unstructured":"Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018;15(1):134. https:\/\/doi.org\/10.1186\/s12974-018-1144-2.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"3269_CR19","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s00415-018-9122-2","volume":"266","author":"R Wynford-Thomas","year":"2019","unstructured":"Wynford-Thomas R, Jacob A, Tomassini V. Neurological update: MOG antibody disease. J Neurol. 2019;266(5):1280\u20136. https:\/\/doi.org\/10.1007\/s00415-018-9122-2.","journal-title":"J Neurol"},{"key":"3269_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.msard.2016.12.009","volume":"12","author":"A Baheerathan","year":"2017","unstructured":"Baheerathan A, Brownlee WJ, Chard DT, Shields K, Gregory R, Trip SA. Antecedent anti-NMDA receptor encephalitis in two patients with multiple sclerosis. Mult Scler Relat Disord. 2017;12:20\u20132. https:\/\/doi.org\/10.1016\/j.msard.2016.12.009.","journal-title":"Mult Scler Relat Disord"},{"key":"3269_CR21","doi-asserted-by":"publisher","first-page":"102075","DOI":"10.1016\/j.msard.2020.102075","volume":"42","author":"B Gulec","year":"2020","unstructured":"Gulec B, Kurucu H, Bozbay S, Dikmen Y, Sayman H, Tuzun E, et al. Co-existence of multiple sclerosis and anti-NMDA receptor encephalitis: a case report and review of literature. Mult Scler Relat Disord. 2020;42:102075. https:\/\/doi.org\/10.1016\/j.msard.2020.102075.","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"3269_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s00115-019-00802-1","volume":"91","author":"H Pr\u00fc\u00df","year":"2020","unstructured":"Pr\u00fc\u00df H, K\u00f6hler S, M\u00fcller S. Autoimmune Enzephalitiden \u2013 diagnostischer und therapeutischer Entscheidungsbaum aus psychiatrischer, neurologischer und ethisch-juristischer Sicht : Vorgehensweise bei fehlender Einwilligungsf\u00e4higkeit und Zul\u00e4ssigkeit von Zwangsbehandlungen. Nervenarzt. 2020;91(2):122\u201330. https:\/\/doi.org\/10.1007\/s00115-019-00802-1.","journal-title":"Nervenarzt."},{"issue":"2","key":"3269_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(12)70310-1.","journal-title":"Lancet Neurol"},{"issue":"2","key":"3269_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1212\/WNL.0000000000000570","volume":"83","author":"RC Dale","year":"2014","unstructured":"Dale RC, Brilot F, Duffy LV, Twilt M, Waldman AT, Narula S, et al. Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. Neurology. 2014;83(2):142\u201350. https:\/\/doi.org\/10.1212\/WNL.0000000000000570.","journal-title":"Neurology."},{"issue":"5","key":"3269_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/00048670801961107","volume":"42","author":"C Rummel-Kluge","year":"2008","unstructured":"Rummel-Kluge C, Schuster T, Peters S, Kissling W. Partial compliance with antipsychotic medication is common in patients with schizophrenia. Aust N Z J Psychiatry. 2008;42(5):382\u20138. https:\/\/doi.org\/10.1080\/00048670801961107.","journal-title":"Aust N Z J Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03269-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-021-03269-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03269-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T07:03:36Z","timestamp":1635836616000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-021-03269-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3269"],"URL":"https:\/\/doi.org\/10.1186\/s12888-021-03269-0","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"assertion":[{"value":"27 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The funding note was missing in the original publication. The article has been updated to rectify the error.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this is a case report describing clinical observations, ethic approval was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient agreed and provided written informed consent for publication of this report. An overseeing mental health expert has ruled that the patient\u00a0has been deemed ethically and medically capable of consenting for their participation in this report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"355"}}